Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myeloma.

Christoph DriessenRouven MüllerUrban NovakNathan CantoniDaniel BetticherNicolas MachAxel RüferUlrich MeyPanagiotis SamarasKarin RibiLenka BesseAndrej BesseCatherine BersetStephanie RondeauHanne HawleFelicitas HitzThomas PabstThilo Zander

Published in: Blood (2018)

Keyphrases

multiple myeloma
low dose
high dose